GREENWICH LIFESCIENCES INC. - COMMON STOCK
11.97
12-فبراير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.04
-0.33%
نطاق اليوم
11.58 - 12.15
ISIN
N/A
المصدر
NASDAQ
-
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
10 فبراير 2025 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
29 يناير 2025 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
27 يناير 2025 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
23 يناير 2025 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Provides Update on Commercial Manufacturing
22 يناير 2025 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
14 يناير 2025 06:15:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
13 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Partners with GIM in Italy
26 نوفمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Provides Update on Corporate Events
18 نوفمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
01 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Set to Join Russell 2000 Index Again
26 يونيو 2024 07:33:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Announces $2.5 Million Private Placement
14 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
13 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
12 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
27 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
22 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
14 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
21 نوفمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >